Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Prostaglandin EP4 antagonists.

Borriello M, Stasi LP.

Pharm Pat Anal. 2013 May;2(3):387-97. doi: 10.4155/ppa.13.15. Review.

PMID:
24237064
2.

Prostaglandin E2 contributes to the synthesis of brain-derived neurotrophic factor in primary sensory neuron in ganglion explant cultures and in a neuropathic pain model.

Cruz Duarte P, St-Jacques B, Ma W.

Exp Neurol. 2012 Apr;234(2):466-81. doi: 10.1016/j.expneurol.2012.01.021. Epub 2012 Jan 27.

PMID:
22309829
3.

Prostaglandins and prostaglandin receptor antagonism in migraine.

Antonova M.

Dan Med J. 2013 May;60(5):B4635. Review.

PMID:
23673269
4.

E-type prostanoid receptor 4 (EP4) in disease and therapy.

Konya V, Marsche G, Schuligoi R, Heinemann A.

Pharmacol Ther. 2013 Jun;138(3):485-502. doi: 10.1016/j.pharmthera.2013.03.006. Epub 2013 Mar 21. Review.

5.

Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.

Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.

Clin Exp Allergy. 2013 Jul;43(7):741-51. doi: 10.1111/cea.12142.

PMID:
23786281
6.

Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.

Burch JD, Farand J, Colucci J, Sturino C, Ducharme Y, Friesen RW, Lévesque JF, Gagné S, Wrona M, Therien AG, Mathieu MC, Denis D, Vigneault E, Xu D, Clark P, Rowland S, Han Y.

Bioorg Med Chem Lett. 2011 Feb 1;21(3):1041-6. doi: 10.1016/j.bmcl.2010.12.014. Epub 2010 Dec 8.

PMID:
21215624
7.

Role of prostaglandin E2 in the synthesis of the pro-inflammatory cytokine interleukin-6 in primary sensory neurons: an in vivo and in vitro study.

St-Jacques B, Ma W.

J Neurochem. 2011 Sep;118(5):841-54. doi: 10.1111/j.1471-4159.2011.07230.x. Epub 2011 Mar 28.

8.

PGE1 and PGE2 modify platelet function through different prostanoid receptors.

Iyú D, Jüttner M, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S.

Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):9-16. doi: 10.1016/j.prostaglandins.2010.11.001. Epub 2010 Nov 21.

PMID:
21095237
9.

Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.

Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y.

Am J Respir Cell Mol Biol. 2013 Mar;48(3):322-9. doi: 10.1165/rcmb.2012-0158OC. Epub 2012 Dec 6.

PMID:
23221043
10.

Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor.

Charo C, Holla V, Arumugam T, Hwang R, Yang P, Dubois RN, Menter DG, Logsdon CD, Ramachandran V.

Pancreas. 2013 Apr;42(3):467-74. doi: 10.1097/MPA.0b013e318264d0f8.

11.

Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells.

Prijatelj M, Celhar T, Mlinaric-Rascan I.

Prostaglandins Other Lipid Mediat. 2011 Aug;95(1-4):19-26. doi: 10.1016/j.prostaglandins.2011.04.001. Epub 2011 May 10.

PMID:
21600299
12.
13.

Prostaglandin E2/EP4 signalling facilitates EP4 receptor externalization in primary sensory neurons in vitro and in vivo.

St-Jacques B, Ma W.

Pain. 2013 Feb;154(2):313-23. doi: 10.1016/j.pain.2012.11.005. Epub 2012 Nov 21.

PMID:
23265688
14.

Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression.

Soontrapa K, Honda T, Sakata D, Yao C, Hirata T, Hori S, Matsuoka T, Kita Y, Shimizu T, Kabashima K, Narumiya S.

Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6668-73. doi: 10.1073/pnas.1018625108. Epub 2011 Apr 1.

15.

Discovery and characterization of a potent and selective EP4 receptor antagonist.

Schiffler MA, Chandrasekhar S, Fisher MJ, Harvey A, Kuklish SL, Wang XS, Warshawsky AM, York JS, Yu XP.

Bioorg Med Chem Lett. 2015 Aug 15;25(16):3176-8. doi: 10.1016/j.bmcl.2015.05.091. Epub 2015 Jun 4.

PMID:
26091726
16.

Prostaglandin receptor EP4 in abdominal aortic aneurysms.

Cao RY, St Amand T, Li X, Yoon SH, Wang CP, Song H, Maruyama T, Brown PM, Zelt DT, Funk CD.

Am J Pathol. 2012 Jul;181(1):313-21. doi: 10.1016/j.ajpath.2012.03.016. Epub 2012 May 15.

PMID:
22595380
17.

Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine.

Myren M, Baun M, Ploug KB, Jansen-Olesen I, Olesen J, Gupta S.

Cephalalgia. 2010 Sep;30(9):1110-22. doi: 10.1177/0333102409357957. Epub 2010 Apr 7.

PMID:
20713561
18.

Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice.

Li N, Zhang L, An Y, Zhang L, Song Y, Wang Y, Tang H.

J Proteome Res. 2015 Mar 6;14(3):1566-73. doi: 10.1021/pr501236y. Epub 2015 Feb 23.

PMID:
25669961
19.

Potential therapeutic interventions via EP2/EP4 prostaglandin receptors.

Zimecki M.

Postepy Hig Med Dosw (Online). 2012 May 30;66:287-94. Review.

20.

Prostaglandin E(2) receptors as potential bone anabolic targets - selective EP4 receptor agonists.

Pagkalos J, Leonidou A, As-Sultany M, Heliotis M, Mantalaris A, Tsiridis E.

Curr Mol Pharmacol. 2012 Jun;5(2):174-81. Review.

PMID:
21787288
Items per page

Supplemental Content

Write to the Help Desk